ABPI report demonstrates value of Scotland’s pharmaceutical industry

Article summary

A new report from the Association of the British Pharmaceutical Industry (ABPI) has recognised the pharmaceutical industry as a key player in Scotland's life sciences sector. The industry has contributed significantly to the country's economy, creating nearly 15,000 high-value jobs, supporting research and development, and providing innovative treatments for patients. The report showed a significant increase in total turnover for pharmaceutical products produced in Scotland, increasing from £690m in 2019 to £1.65bn in 2022, despite the coronavirus (COVID-19) pandemic. The report also included less positive findings, such as a £70m decrease in exports between 2018 and 2019, which has resulted in the ABPI calling on the Scottish Government to take action to maximise the sector’s potential in the long-term. The ABPI further highlighted the importance of continued investment in the sector to maintain Scotland's position as a leader in life sciences.